BR0002381A - Agente para aumentar a liberação de acetilcolina no cérebro - Google Patents
Agente para aumentar a liberação de acetilcolina no cérebroInfo
- Publication number
- BR0002381A BR0002381A BR0002381-7A BR0002381A BR0002381A BR 0002381 A BR0002381 A BR 0002381A BR 0002381 A BR0002381 A BR 0002381A BR 0002381 A BR0002381 A BR 0002381A
- Authority
- BR
- Brazil
- Prior art keywords
- anisoyl
- brain
- release
- acetylcholine
- gaba
- Prior art date
Links
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004373 acetylcholine Drugs 0.000 title abstract 4
- 210000004556 brain Anatomy 0.000 title abstract 3
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 abstract 6
- DZTVZKSCFQIBMV-UHFFFAOYSA-N 4-[(4-methoxybenzoyl)amino]butanoic acid Chemical compound COC1=CC=C(C(=O)NCCCC(O)=O)C=C1 DZTVZKSCFQIBMV-UHFFFAOYSA-N 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000017164 Chronobiology disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940124277 aminobutyric acid Drugs 0.000 abstract 1
- 230000006399 behavior Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"AGENTE PARA AUMENTAR A LIBERAçãO DE ACETILCOLINA NO CéREBRO"<D>. A presente invenção refere-se à utilização do ácido N-anisoil-<SYM> aminobutírico (N-anisoil-GABA) ou do ácido p-anísico para a preparação de uma composição farmacêutica que melhora a liberação de acetilcolina (ACh) no cérebro. Em particular, a invenção refere-se ao uso do composto N-anisoil-GABA ou do ácido p-anísico para o tratamento de distúrbios do ritmo circadiano, distúrbios do sono, distúrbios da deficiência de atenção e comportamentos problemáticos. A invenção também refere-se a composições farmacêuticas compreendendo o N-anisoil-GABA ou o ácido p-anísico como um ingrediente ativo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99108223 | 1999-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0002381A true BR0002381A (pt) | 2000-11-07 |
Family
ID=8238054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0002381-7A BR0002381A (pt) | 1999-04-27 | 2000-04-26 | Agente para aumentar a liberação de acetilcolina no cérebro |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20030073744A1 (pt) |
| JP (1) | JP2000309529A (pt) |
| KR (1) | KR100372906B1 (pt) |
| CN (1) | CN1277019A (pt) |
| AR (1) | AR023763A1 (pt) |
| AT (1) | AT408836B (pt) |
| AU (1) | AU3011300A (pt) |
| BE (1) | BE1013314A3 (pt) |
| BR (1) | BR0002381A (pt) |
| CA (1) | CA2307022A1 (pt) |
| DE (1) | DE10020237A1 (pt) |
| DK (1) | DK200000687A (pt) |
| ES (1) | ES2176078A1 (pt) |
| FI (1) | FI20000977A (pt) |
| FR (1) | FR2792833B1 (pt) |
| GB (1) | GB2351662A (pt) |
| GR (1) | GR1003591B (pt) |
| IE (1) | IE20000308A1 (pt) |
| IT (1) | IT1318490B1 (pt) |
| NL (1) | NL1015043C2 (pt) |
| PT (1) | PT102456B (pt) |
| SE (1) | SE0001499L (pt) |
| TR (1) | TR200001133A2 (pt) |
| ZA (1) | ZA200002041B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5273731B2 (ja) * | 2009-08-11 | 2013-08-28 | 独立行政法人産業技術総合研究所 | 生体リズムの制御剤 |
| CN111629602A (zh) * | 2018-11-13 | 2020-09-04 | 黄华成 | 一种氨基酸的酰基化衍生物在制备动物饲料添加剂中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU21107A3 (es) * | 1978-02-10 | 1988-02-01 | Hoffmann La Roche | Pyrrolidines derivatives |
| JPH1081607A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | 抗菌剤 |
| JPH1081626A (ja) * | 1996-09-06 | 1998-03-31 | Kamiyama:Kk | チロシナーゼ活性阻害剤 |
-
2000
- 2000-04-21 FR FR0005180A patent/FR2792833B1/fr not_active Expired - Fee Related
- 2000-04-21 IT IT2000MI000914A patent/IT1318490B1/it active
- 2000-04-24 JP JP2000121904A patent/JP2000309529A/ja active Pending
- 2000-04-24 KR KR10-2000-0021630A patent/KR100372906B1/ko not_active IP Right Cessation
- 2000-04-24 GR GR20000100145A patent/GR1003591B/el unknown
- 2000-04-25 AR ARP000101934A patent/AR023763A1/es not_active Application Discontinuation
- 2000-04-25 DK DK200000687A patent/DK200000687A/da not_active Application Discontinuation
- 2000-04-25 ZA ZA200002041A patent/ZA200002041B/xx unknown
- 2000-04-25 IE IE20000308A patent/IE20000308A1/en not_active IP Right Cessation
- 2000-04-25 AT AT0071600A patent/AT408836B/de not_active IP Right Cessation
- 2000-04-25 DE DE10020237A patent/DE10020237A1/de not_active Withdrawn
- 2000-04-25 GB GB0010049A patent/GB2351662A/en not_active Withdrawn
- 2000-04-26 CA CA002307022A patent/CA2307022A1/en not_active Abandoned
- 2000-04-26 BR BR0002381-7A patent/BR0002381A/pt not_active IP Right Cessation
- 2000-04-26 BE BE2000/0294A patent/BE1013314A3/fr not_active IP Right Cessation
- 2000-04-26 ES ES200001063A patent/ES2176078A1/es active Pending
- 2000-04-26 TR TR2000/01133A patent/TR200001133A2/xx unknown
- 2000-04-26 PT PT102456A patent/PT102456B/pt not_active IP Right Cessation
- 2000-04-26 FI FI20000977A patent/FI20000977A/fi not_active IP Right Cessation
- 2000-04-26 AU AU30113/00A patent/AU3011300A/en not_active Abandoned
- 2000-04-26 SE SE0001499A patent/SE0001499L/ unknown
- 2000-04-27 NL NL1015043A patent/NL1015043C2/nl not_active IP Right Cessation
- 2000-04-27 CN CN00118155A patent/CN1277019A/zh active Pending
-
2002
- 2002-12-04 US US10/309,434 patent/US20030073744A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908488A (pt) | Composição farmacêutica de topiramato | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| BR0110767A (pt) | Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina | |
| SE0001899D0 (sv) | New compounds | |
| EP2263667A3 (en) | Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol | |
| BRPI0414876A (pt) | compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos | |
| MY144992A (en) | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives. | |
| BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
| BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
| BRPI0408655A (pt) | formulações compreendendo um agente ativo e cacau em pó e a sua utilização | |
| BR9906920A (pt) | "tts contendo um antioxidante" | |
| BR9807319A (pt) | Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos. | |
| BR9914419A (pt) | Terapia para melhoria da percepção | |
| HUP0303454A2 (hu) | 4-Ciano-trifluor-3-(4-fluor-fenil-szulfonil)-2-hidroxi-2-metil-propiono-m-toluididet és pvp-t tartalmazó szilárd gyógyászati készítmény | |
| UA92498C2 (ru) | Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм | |
| BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
| BR9913135A (pt) | Formulação oral | |
| BRPI9910024B8 (pt) | uso de uma mistura de alcoóis de açúcar contendo 6-o-alfa-d-glicopiranosil-d-sorbitol (1,6-gps) e 1-o-alfa-d-glicopiranosil-d-manitol (1,1-gpm) in vitro, e composição farmacêutica para consumo humano ou animal | |
| BR9706889A (pt) | Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba | |
| WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
| BR0002381A (pt) | Agente para aumentar a liberação de acetilcolina no cérebro | |
| CA2291650A1 (fr) | Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant | |
| BR9912533A (pt) | Composição farmacêutica tendo sabor melhorado | |
| BR0212744A (pt) | Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas | |
| BR0210063A (pt) | Composição estável e uso da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |